Susquehanna Fundamental Investments, LLC Rocket Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 11, 2021	SELL	$39.41 - $47.25 $1.02 Million - $1.22 Million	-25,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $1.12 Million - $1.71 Million	25,900 New	25,900 $1.15 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.